Submission period
Overview Talk and Symposium: June 3 – July 12, 2024
Workshop (Oral and Poster): June 3 – July 12, 2024
■IMPORTANT■
- In principle, you must attend onsite to deliver regular presentations and participate in discussions.
- All abstracts must be submitted in English.
- All presentation slides for Workshop (Oral session) must be prepared in English, and all presentations are to be delivered in English. Japanese may be permitted during discussions at each chair’s discretion.
- In principle, oral presentations at Workshop are to be delivered onsite. No real-time or on-demand distribution of presentations will be conducted. *Some presenters, such as those from overseas, may be approved to deliver online presentations.
- All poster presentations must be delivered in English. Japanese may be permitted during discussions.
- You can choose either “Oral presentation” or “Poster presentation only” when you submit an abstract. Those who choose “Oral presentation” are required to deliver a poster presentation as well. However, the coordinators may ask presenters to change from oral to poster presentations or vice versa, depending on the number of submissions.
- All poster presenters must attend onsite to deliver their presentations by putting up their posters and join discussions. No online sessions, such as e-poster and video calls, will be conducted.
■Life Events■
Onsite presentation is required in principle; however, if you are unable to attend the meeting in person due to life events such as physical disability, pregnancy, childcare, or nursing care, the organizing committee will consider alternative presentation methods for you. Please send a message stating the reason for your difficulty to conf-jsi@meneki.or.jp by the submission deadline, July 12. If the deadline is extended, please send it by the extended deadline.
The message must include your abstract submission number, name, affiliation, and the reason for your difficulty, with the subject line “53rd Life Event.” If you do not hear from us within one week of your initial message, please resend it.
Eligibility
Presenting authors must be JSI members: Regular, Student, Meritorious and Honorary members. However, foreign-registered authors residing outside Japan are excluded.
For inquiries or information regarding JSI membership, please contact the JSI Secretariat.
Presentation condition
One person can submit one paper as a first author. One person cannot submit multiple papers as a first author.
Presentation Language
All presentation slides and posters must be prepared in English and all presentations are to be delivered in English. Japanese may be permitted during discussions at each chair’s discretion.
| Program | Abstract | Presentation slides | Presentation | Comments |
|---|---|---|---|---|
| Overview Talk | English | English | Decided at chairs’ discretion |
|
| Symposium | English | English | English | |
| Workshop | English | English | English | At discussions, Japanese may be permitted at chairs’ discretion. |
| Poster Session | English | ー | English | Japanese also permitted. |
| Technical/Clinical/ Afternoon Seminar |
English | English or Japanese |
English or Japanese |
Categories and Keywords
All authors will be asked to select a category from the 12 categories below. Visit here for details including keywords.
| 1 | Hematopoiesis and Immune Environment |
|---|---|
| 2 | B cells |
| 3 | T cells |
| 4 | Innate lymphocytes |
| 5 | Dendritic cells, macrophages, granulocytes |
| 6 | Allergy |
| 7 | Cytokines and chemokines |
| 8 | Tolerance and Immune suppression |
| 9 | Virus infection Bacterial / mycofungal / parasite infection |
| 10 | Autoimmune diseases |
| 11 | Allergy |
| 12 | Tumor immunity |
Best Presentation Award
The Best Presentation Award will be given to those who deliver an excellent oral presentation (Workshop) or poster presentation. Visit here for more information on the award.
COI Disclosure
The management of COI Disclosure (Disclosure of Conflict of Interest) is essential to avoid future risk of bias in order to promote industry-academia collaboration. The Japanese Society of Immunology (JSI) established the Ethic and COI Committee in 2012, which has been managing COI Disclosure from the 43rd JSI annual meeting. This meeting, the 53rd JSI annual meeting, requires all presenters to disclose their COI status by entering information during the submission process and presenting it on their presentation slides or posters based on the "COI Guidelines."
Registration required prior to abstract submission
Please register before submitting an abstract. Once your registration is complete, you may proceed to the abstract submission page. For more information on Registration, please visit here.
＜Notes＞
Please read the following carefully before submitting an abstract.
Character limit: 1,691 characters including space and line breaks.
Number of authors: Up to 12 authors, including a first author, can be registered.
Number of affiliations: Up to 10 affiliations can be registered.
Entering names:
Capitalize the first letter of both the first and family names (e.g., 〇 Taro Yamada, × Taro YAMADA)
Register, view and modify abstracts on your own responsibility. Registered information will be published in the meeting program or posted on the website as entered. The submitting author is responsible for ensuring the correct entry of all information, including the names and affiliations of all co-authors.
Confirmation Email
Once you complete the abstract submission, you will receive a confirmation email. Your abstract number will be included in the confirmation email. You will need this number to modify your abstract or to send an inquiry to the secretariat. Please print out the page or save it on your computer and ensure you keep it safe.
Reviewing result
Reviewing results will be announced on our website. Accepted abstract numbers will be posted on our website in early October. Notification emails will not be sent to those who submitted abstracts directly.
＜The flow of abstract submission: For those who have not completed registration＞
↓
↓
